(Q37292997)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852531%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Somatostatin analogs and gallstones: a retrospective survey on a large series of acromegalic patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852531%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852531%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Carla Scaroni

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852531%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

A Mainolfi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852531%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

F Grimaldi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852531%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

R Cozzi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852531%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

M Montini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852531%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

C Carzaniga

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852531%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

S Grottoli

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852531%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

L Cortesi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852531%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

M Albizzi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852531%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

R M Testa

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852531%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

L Fatti

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852531%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

D De Giorgio

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852531%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

F Cavagnini

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852531%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

P Loli

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852531%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

G Pagani

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852531%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

E Ghigo

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852531%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

1 August 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852531%20AND%20SRC:MED&resulttype=core&format=json

Journal of Endocrinological Investigation

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852531%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852531%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852531%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

704-710

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852531%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf03346419

15 January 2020

exact match

0 references

cites work

Medical progress: Acromegaly

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Systemic complications of acromegaly: epidemiology, pathogenesis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

A nationwide survey of mortality in acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Long-acting somatostatin analog therapy of acromegaly: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Role of liver function tests in predicting common bile duct stones in acute calculous cholecystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Cholesterol gallstones: from epidemiology to prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Review: pathogenesis of gallstones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Diet as a risk factor for cholesterol gallstone disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Increased deoxycholic acid absorption and gall stones in acromegalic patients treated with octreotide: more evidence for a connection between slow transit constipation and gall stones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Deoxycholic acid and the pathogenesis of gall stones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Intestinal transit, deoxycholic acid and the cholesterol saturation of bile--three inter-related factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Prolonged large bowel transit increases serum deoxycholic acid: a risk factor for octreotide induced gallstones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Severe impairment of postprandial cholecystokinin release and gall-bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Changes in glucose tolerance and development of gall stones during high dose treatment with octreotide for acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Gallstones during octreotide therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Effect of octreotide on gall stone prevalence and gall bladder motility in acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Octreotide induced prolongation of colonic transit increases faecal anaerobic bacteria, bile acid metabolising enzymes, and serum deoxycholic acid in patients with acromegaly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Effects of octreotide on biliary lipid composition and occurrence of cholesterol crystals in patients with acromegaly. A prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Differing effects on gall-bladder motility of lanreotide SR and octreotide LAR for treatment of acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Roles of gall bladder emptying and intestinal transit in the pathogenesis of octreotide induced gall bladder stones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Mechanism for the transit-induced increase in colonic deoxycholic acid formation in cholesterol cholelithiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Increasing butyrate concentration in the distal colon by accelerating intestinal transit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Postprandial gall bladder motility and hormone release during intermittent and continuous subcutaneous octreotide treatment in acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Efficacy and tolerability of the long-acting somatostatin analog lanreotide in acromegaly. A 12-month multicenter study of 58 acromegalic patients. French Multicenter Study Group on Lanreotide in Acromegaly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Results of a European multicentre study with Sandostatin LAR in acromegalic patients. Sandostatin LAR Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Sonography of gallbladder abnormalities in acromegaly patients following octreotide and ursodiol therapy: incidence and time course

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Gallbladder function in acromegalic patients taking long-term octreotide: evidence of rebound hypermotility on cessation of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Withdrawal of somatostatin analogue therapy in patients with acromegaly is associated with an increased risk of acute biliary problems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

The natural history of gallstones: the GREPCO experience. The GREPCO Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Bile acid dissolution therapy of gallbladder stones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Ursodeoxycholic acid alone or with chenodeoxycholic acid for dissolution of cholesterol gallstones: a randomized multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Composition of gall bladder stones associated with octreotide: response to oral ursodeoxycholic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

21 January 2018

Gallstones: pathogenesis

1 reference

https://api.crossref.org/works/10.1007%2FBF03346419

Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.

21 January 2018

1 reference

12 December 2020

Determinants of clinical outcome and survival in acromegaly

1 reference

12 December 2020

The impact of continuous subcutaneous infusion of octreotide on gallstone formation in acromegalic patients

1 reference

12 December 2020

Octreotide acetate inhibits motility in the rabbit distal colon

1 reference

12 December 2020

Acute pancreatitis following octreotide withdrawal

1 reference

12 December 2020

Growth hormone treatment does not alter biliary lipid metabolism in healthy adult men

1 reference

12 December 2020

Dietary intake and gallbladder disease: a review

1 reference

12 December 2020

Deoxycholic acid influences cholesterol solubilization and microcrystal nucleation time in gallbladder bile

1 reference

12 December 2020

The role of bile composition and physical chemistry in the pathogenesis of octreotide-associated gallbladder stones

1 reference

12 December 2020

Factors influencing mortality in acromegaly

1 reference

12 December 2020

Restoration of gallbladder contractility after withdrawal of long-term octreotide therapy in acromegalic patients

1 reference

12 December 2020

Cholelithiasis and acromegaly: therapeutic strategies.

1 reference

12 December 2020

Ursodeoxycholic acid alone or with chenodeoxycholic acid for dissolution of cholesterol gallstones: a randomized multicentre trial. The British-Italian Gallstone Study group

1 reference

12 December 2020

Somatostatinoma syndrome: does a clinical entity exist?

1 reference

12 December 2020

Effects of somatostatin on gallbladder emptying

1 reference

12 December 2020

Genetics of gallstone disease.

1 reference

12 December 2020

Criteria for cure of acromegaly: a consensus statement

1 reference

12 December 2020

The role of human growth hormone in the regulation of cholesterol and bile acid metabolism

1 reference

12 December 2020

Mortality in acromegaly

1 reference

12 December 2020

Octreotide-associated biliary tract dysfunction and gallstone formation: pathophysiology and management

1 reference

12 December 2020

An audit of outcome of treatment in acromegaly.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03346419

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852531%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference